NR0B2 and hepatocellular carcinoma: SHP-1 was reported to exert tyrosine phosphatase activity that directly downregulated pSTAT3 (Tyr705) and was a potent inhibitor of EMT in HCC and colorectal cancer (CRC) (Figure 3) [79,80].